Nanoscope Therapeutics Press Releases
-
Nanoscope Appoints Two Pharmaceutical Industry Veterans as Scientific and Clinical Advisors
May 25, 2022 by Nanoscope Therapeutics
-
Nanoscope’s Clinical and Scientific Advances in Optogenetics to be Featured at ASGCT Annual Meeting, May 16-19, 2022 in Washington, DC
May 13, 2022 by Nanoscope Therapeutics
-
Nanoscope’s Vision-Restoring Optogenetic Gene Therapy to be Featured in Multiple Presentations as Part of ARVO Annual Meeting in Denver May. 1-4, 2022
April 26, 2022 by Nanoscope Therapeutics
-
Nanoscope Therapeutics Appoints Pharma Industry Veteran Aaron Osborne, MBBS, as Chief Medical Officer and Chief Development Officer
April 18, 2022 by Nanoscope Therapeutics
Nanoscope Therapeutics In the News
- Retina Synthesis: Optogenetics Interview with Samarendra Mohanty, PhD and Charles Wykoff, MD
- Healio: Gene therapy platform for Stargardt macular degeneration receives IND clearance
- Ophthalmology Times: Nanoscope Therapeutics announces FDA clearance of IND for MCO-010 gene therapy in Stargardt patients
- Photonics West BIOS Show Daily: Optogenetics a Promising Route to Vision Restoration
- Ft Worth Business Press: TechFW Client Nanoscope Receives $1.5M Grant to Move Macular Degeneration Therapy Forward
Upcoming Nanoscope Therapeutics Events
- June 8-11 2022 | The Macula Society Annual Meeting | Berlin
- June 21-22, 2022 | 8th Annual Brain Initiative Meeting
- July 13-16, 2022 | American Society of Retina Specialists Annual Meeting | New York
- Sept 30 – Oct 3, 2022 | American Academy of Ophthalmology Annual Meeting | Chicago
- Nov 2-5, 2022 | The Retina Society Annual Scientific Meeting | Pasadena, CA
Media Contact
Opus Biotech Communications
Daniel Eramian
daniel.eramian@comcast.net
425-306-8716
Charles Craig
charles.s.craig@gmail.com
404-245-0591